Since PXR expression does not affect colon cancer cells proliferation, we hypothesized that SN38 resistance observed in PXR-expressing cells is likely mediated through transcriptional regulation of genes involved in drug metabolism. This evidence concerns the gene NR1I2 and malignant colon neoplasm.